Free Trial

Life Science REIT (LON:LABS) Stock Price Down 0.5% - What's Next?

Life Science REIT logo with Real Estate background

Life Science REIT plc (LON:LABS - Get Free Report)'s share price was down 0.5% during mid-day trading on Tuesday . The company traded as low as GBX 36.70 ($0.46) and last traded at GBX 36.70 ($0.46). Approximately 321,672 shares traded hands during trading, a decline of 21% from the average daily volume of 409,043 shares. The stock had previously closed at GBX 36.90 ($0.46).

Analyst Ratings Changes

LABS has been the topic of several research analyst reports. Berenberg Bank reissued a "buy" rating and set a GBX 57 ($0.71) target price on shares of Life Science REIT in a research note on Thursday, October 3rd. Shore Capital reissued a "buy" rating on shares of Life Science REIT in a research report on Thursday, September 26th.

View Our Latest Research Report on Life Science REIT

Life Science REIT Trading Down 3.8 %

The firm has a market cap of £123.55 million, a P/E ratio of -588.33 and a beta of 0.08. The business's fifty day simple moving average is GBX 39.21 and its 200-day simple moving average is GBX 36.60.

Life Science REIT Company Profile

(Get Free Report)

Life Science REIT plc (the Company) is a closed-ended Real Estate Investment Trust (REIT) incorporated in England and Wales on 27 July 2021. The Company began trading on 19 November 2021 and its shares are admitted to trading on the Premium Listing Segment of the Main Market of the London Stock Exchange.

Featured Stories

Should You Invest $1,000 in Life Science REIT Right Now?

Before you consider Life Science REIT, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Life Science REIT wasn't on the list.

While Life Science REIT currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Unlock the Potential in Options Trading Cover

Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025
Investing in Quantum Computing: Is Rigetti the Stock to Watch?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines